- Home
- FENC vs TMTS Comparison
FENC vs TMTS Comparison
Compare FENC & TMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SELL
Current Price
$9.98
Company Overview
Basic Information| Metric | FENC | TMTS |
|---|---|---|
| Founded | 1996 | 2025 |
| Country | United States | United States |
| Employees | 35 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 350.0M | 308.7M |
| IPO Year | 2010 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FENC | TMTS |
|---|---|---|
| Price | $9.98 | $10.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | ★ 115.9K | 112.1K |
| Earning Date | 11-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $62.55 | N/A |
| Revenue Next Year | $42.10 | N/A |
| P/E Ratio | $172.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $10.00 |
| 52 Week High | $13.25 | $10.09 |
Technical Indicators
Market Signals| Indicator | FENC | TMTS |
|---|---|---|
| Relative Strength Index (RSI) | 40.60 | 35.01 |
| Support Level | $9.87 | N/A |
| Resistance Level | $10.66 | $10.04 |
| Average True Range (ATR) | 0.49 | 0.01 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 12.90 | 22.22 |
Price Performance
Historical Comparison FENC
TMTS
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About TMTS Spartacus Acquisition Corp. II Class A Ordinary Shares
Spartacus Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.